Pharvaris
Pharvaris is a clinical-stage company developing oral bradykinin-B2-receptor antagonists, aiming to provide patients with effective, targeted treatments for conditions linked to this clinically validated therapeutic pathway.
About Pharvaris
Pharvaris is a clinical-stage biopharmaceutical company focused on developing novel oral bradykinin B2 receptor antagonists for patients suffering from hereditary angioedema (HAE) and other bradykinin-mediated diseases. Founded in 2015, the company targets a clinically validated pathway using innovative small-molecule therapies, aiming to provide effective oral alternatives to existing injectable treatments across all sub-types of HAE. Backed by a leadership team with deep expertise in pharmaceutical development and rare diseases, Pharvaris is advancing next-generation therapies designed to improve patient convenience, safety, and quality of life.
Recently Added Startups
Cellestia
Cellestia Biotech is a biotechnology company developing small-molecule cancer therapeutics targeting the NOTCH signaling pathway, aiming to deliver more precise and effective treatments for patients with oncology needs.
PROGNOSIX
Prognosix AG enables better decision-making through data science and AI forecasting, using algorithmic predictions that deliver significantly more accurate planning, helping organisations make processes more predictable and future-ready.
IQONIQ
IQONIQ is a fan engagement platform for sports and entertainment, enabling fans worldwide to connect more deeply with athletes, idols, and clubs through a unified, interactive, and rewarding digital ecosystem.
Related Post
Top 10 HealthTech Startups in Denmark
Haleon Share Price Prediction (2025–2030): Expert Analysis & Forecasts
Business Opportunities in Hungary
Manufacturing
Boomerang
Boomerang brings sustainability to e-commerce by replacing single-use shipping packages with reusable ones. Its intelligent deposit and return logistics system enables packaging to be reused up to 50 times, reducing waste.
ASPIVIX
Aspivix is a Swiss and California-based manufacturer of medical devices for women's health.
Switzerland
Pharvaris
Pharvaris is a clinical-stage company developing oral bradykinin-B2-receptor antagonists, aiming to provide patients with effective, targeted treatments for conditions linked to this clinically validated therapeutic pathway.
Hempfy
Hempfy specializes in cutting-edge foods and drinks that are harvested using exclusive cold infusion technology.